STIs

News

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

GSK has reported topline results from a phase 3 trial of its novel antibiotic gepotidacin that could spell the end of a decades-long drought in new oral therapies for gonorrhoea.

News

Africa-led HIV vaccine trial ends in failure

A trial viewed as the best hope of finding an effective HIV vaccine this decade has ended in failure in another major setback for the field.

News

Innoviva’s ‘game changer’ antibiotic tackles gonorrhoea

Innoviva has moved a step closer to bringing the first novel antibiotic to market for gonorrhoea in decades after reporting positive results in a phase 3 trial.

GSK antibiotic gepotidacin clears phase 3 gonorrhoea trial

Africa-led HIV vaccine trial ends in failure

Innoviva’s ‘game changer’ antibiotic tackles gonorrhoea

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Editor's Picks